Literature DB >> 11450850

The genomic structure and expression of MJD, the Machado-Joseph disease gene.

Y Ichikawa1, J Goto, M Hattori, A Toyoda, K Ishii, S Y Jeong, H Hashida, N Masuda, K Ogata, F Kasai, M Hirai, P Maciel, G A Rouleau, Y Sakaki, I Kanazawa.   

Abstract

Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder that is clinically characterized by cerebellar ataxia and various associated symptoms. The disease is caused by an unstable expansion of the CAG repeat in the MJD gene. This gene is mapped to chromosome 14q32.1. To determine its genomic structure, we constructed a contig composed of six cosmid clones and eight bacterial artificial chromosome (BAC) clones. It spans approximately 300kb and includes MJD. We also determined the complete sequence (175,330bp) of B445M7, a human BAC clone that contains MJD. The MJD gene was found to span 48,240bp and to contain 11 exons. Northern blot analysis showed that MJD mRNA is ubiquitously expressed in human tissues, and in at least four different sizes; namely, 1.4, 1.8, 4.5, and 7.5kb. These different mRNA species probably result from differential splicing and polyadenylation, as shown by sequences of the 21 independent cDNA clones isolated after the screening of four human cDNA libraries prepared from whole brain, caudate, retina, and testis. The sequences of these latter clones relative to the MJD gene in B445M7 indicate that there are three alternative splicing sites and eight polyadenylation signals in MJD that are used to generate the differently sized transcripts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450850     DOI: 10.1007/s100380170060

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  24 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

Review 2.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

Review 3.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

4.  Sequence analysis of 5' regulatory regions of the Machado-Joseph disease gene (ATXN3).

Authors:  Conceição Bettencourt; Mafalda Raposo; Nadiya Kazachkova; Cristina Santos; Teresa Kay; João Vasconcelos; Patrícia Maciel; Karina C Donis; Maria Luiza Saraiva-Pereira; Laura B Jardim; Jorge Sequeiros; Jácome Bruges-Armas; Manuela Lima
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

5.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

6.  Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal).

Authors:  Conceição Bettencourt; Raquel Nunes Fialho; Cristina Santos; Rafael Montiel; Jácome Bruges-Armas; Patrícia Maciel; Manuela Lima
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

7.  Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties.

Authors:  Ginny Marie Harris; Katerina Dodelzon; Lijie Gong; Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.

Authors:  Conceição Bettencourt; Cristina Santos; Rafael Montiel; Teresa Kay; João Vasconcelos; Patrícia Maciel; Manuela Lima
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

9.  Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.

Authors:  Kathryn M Donaldson; Wei Li; Keith A Ching; Serge Batalov; Chih-Cheng Tsai; Claudio A P Joazeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

10.  Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3).

Authors:  Conceição Bettencourt; Cristina Santos; Rafael Montiel; Maria do Carmo Costa; Pablo Cruz-Morales; Liliana Ribeiro Santos; Nelson Simões; Teresa Kay; João Vasconcelos; Patrícia Maciel; Manuela Lima
Journal:  Neurogenetics       Date:  2009-08-28       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.